Raymond Kreienkamp, MD, PhD

Director, Diabetes Genetics Clinic; Attending Physician, Division of Endocrinology
Instructor, Harvard Medical School
Raymond Kreienkamp, MD, PhD
NPI 1205496643
Print Profile
Request an Appointment
View Research Profile
Locations

Raymond Kreienkamp, MD, PhD

Director, Diabetes Genetics Clinic; Attending Physician, Division of Endocrinology
Instructor, Harvard Medical School

Medical Services

Programs & Services
Diabetes Program
Endocrinology
Conditions & Treatments
22q11.2 Deletion Syndrome
Addison’s Disease
Childhood Obesity
Cushing's Syndrome
Diabetes Insipidus
Genetic Disorders
Growth Hormone Deficiency
Growth Problems
Hashimoto Thyroiditis
Hyperparathyroidism
Hyperthyroidism
Hypocalcemia
Hypoglycemia and Low Blood Sugar
Hypopituitarism
Hypothyroidism
Menstrual Irregularities
Multiple Endocrine Neoplasia
Premature Adrenarche
Progeria
Type 1 Diabetes
Type 2 Diabetes
Education
Undergraduate School
Saint Louis University
2011
St. Louis
MO
Graduate School
Saint Louis University
2017
St. Louis
MO
Medical School
Saint Louis University
2019
St. Louis
MO
Internship
Pediatrics
St. Louis Children's Hospital/Washington University School of Medicine
2020
St. Louis
MO
Residency
Pediatrics
St. Louis Children's Hospital/Washington University School of Medicine
2021
St. Louis
MO
Fellowship
Pediatric Endocrinology
Boston Children's Hospital
2025
Boston
MA
Certifications
American Board of Pediatrics (General)
Professional History

Dr. Kreienkamp completed his undergraduate degree at Saint Louis University, where he studied Chemistry and Economics. He then entered the MD/PhD program at Saint Louis University, where he received a PhD in Biochemistry & Molecular Biology and MD. His PhD studies were focused on the pathophysiology of Hutchinson-Gilford Progeria Syndrome, a rare premature aging disease. He then completed his residency in pediatrics at St. Louis Children's Hospital, before coming to Boston Children's Hospital for his pediatric endocrinology fellowship.

Dr. Kreienkamp is a physician-scientist. His research is focused on the genetic causes of diabetes. Specifically, he is interested in characterizing rare genetic causes of diabetes, as well as studying how genetic tools can improve the care and recognition of the more common type 1 and type 2 diabetes.

Currently, he serves as the Director of the Diabetes Genetics Clinic at Boston Children's Hospital, and he is a member of the teplizumab team at Boston Children's Hospital. He is dedicated to the care of all of his patients with pediatric endocrine conditions, seeing patients across the spectrum of pediatric endocrine conditions.

Approach to Care
My overarching goal is to help patients live their lives to their fullest extent, no matter what endocrine condition they may have. I aim to provide top notch care for all.

Publications

Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score. View Abstract
Lonafarnib Clinical Trials Demonstrate Uncoupling of the Muscle-Bone Unit in Hutchinson-Gilford Progeria Syndrome. View Abstract
The impact of ancestry on performance of type 1 diabetes genetic risk scores: high discrimination performance is maintained in African ancestry populations, but population specific thresholds may improve risk prediction. View Abstract
Development and Validation of a Type 1 Diabetes Multi-Ancestry Polygenic Score. View Abstract
Type 1 Diabetes Polygenic Scores Improve Diagnostic Accuracy in Pediatric Diabetes Care. View Abstract
Genome-Wide Association Study of Quantitative Kidney Function in 52,531 Individuals with Diabetes Identifies Five Diabetes-Specific Loci. View Abstract
An Atypical Presentation of Cytokine Release Syndrome With Signs of Arthritis During Treatment With Teplizumab in a Pediatric Patient. View Abstract
Type 1 Diabetes Polygenic Scores Improve Diagnostic Accuracy in Pediatric Diabetes Care. View Abstract
Advancing Monogenic Diabetes Research and Clinical Care by Creating a Data Commons: The Precision Diabetes Consortium (PREDICT). View Abstract
MODY Calculator and Clinical Features Routinely Used to Distinguish MODY From Type 2 Diabetes in Adults Perform Poorly for Youth Clinically Diagnosed With Type 2 Diabetes. View Abstract
Identification of atypical pediatric diabetes mellitus cases using electronic medical records. View Abstract
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. View Abstract
Precision subclassification of type 2 diabetes: a systematic review. View Abstract
Severe Hypercalcemia due to Hypervitaminosis D in a Breastfed Infant. View Abstract
Systematic review of precision subclassification of type 2 diabetes. View Abstract
Vitamin B6 deficiency with normal plasma levels of pyridoxal 5'-phosphate in perinatal hypophosphatasia. View Abstract
Metabolic Dysfunction in Hutchinson-Gilford Progeria Syndrome. View Abstract
Hutchinson-Gilford Progeria Syndrome: Challenges at Bench and Bedside. View Abstract
Hutchinson-Gilford Progeria Syndrome: A premature aging disease caused by LMNA gene mutations. View Abstract
Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes. View Abstract
DNA repair defects and genome instability in Hutchinson-Gilford Progeria Syndrome. View Abstract
Locations